STAR / FY26 summary

The year in one view.

Strides Pharma Science · annual summary assembled from the available FY26 source records.

Research layer active

Revenue across quarters

1,195

₹ Cr where applicable

PAT across quarters

208

₹ Cr where applicable

Source quarters

1

₹ Cr where applicable

PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q3 FY26: 208 · Watch source sentimentQ3 FY26208208
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.